trending Market Intelligence /marketintelligence/en/news-insights/trending/d-Ef0WyYYlArgNw4CyHDGQ2 content esgSubNav
In This List

Esperion Therapeutics appoints director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Esperion Therapeutics appoints director

Esperion Therapeutics Inc. appointed Jeffrey Berkowitz as a class 2 director of the company.

Berkowitz's term expires at the Ann Arbor, Mich.-based company's 2018 annual shareholders meeting.

He was previously an executive vice president of Optum Inc., UnitedHealth Group Inc.'s health services platform business.